ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for ddt Track real-time Director Deals activity on the London Stock Exchange (LSE)

GDR Genedrive Plc

1.40
-0.05 (-3.45%)
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -3.45% 1.40 1.35 1.45 1.45 1.40 1.45 2,297,892 11:27:14
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 501k -7.08M -0.0113 -1.24 9.06M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 1.45p. Over the last year, Genedrive shares have traded in a share price range of 1.31p to 4.875p.

Genedrive currently has 624,895,408 shares in issue. The market capitalisation of Genedrive is £9.06 million. Genedrive has a price to earnings ratio (PE ratio) of -1.24.

Genedrive Share Discussion Threads

Showing 34726 to 34748 of 34750 messages
Chat Pages: 1390  1389  1388  1387  1386  1385  1384  1383  1382  1381  1380  1379  Older
DateSubjectAuthorDiscuss
15/6/2025
09:02:43
Seems as if insurance foots the bill to some extent in the US.
But do get hold of the article it is fascinating.
I have the paper version so won't copy it.

hazl
15/6/2025
08:59:24
The Sunday Times yet again points out how it is for companies in the UK.
Those in the pharmaceutical industry particularly.

A very interesting article about James Harrison, a genius of sorts, I would say, who has developed a British company called Cycle Pharmaceuicals, catering for rare diseases...that I had been given to understand were not worth bothering with because of lack of profit!

Where's the moral case in that?

However, the difference here, is that James respects where he got brought up and where he got his degree... Cambridge... and has made it work.
Staying in the UK.

How has he done that?

From what I gather by selling in the US.

'The same model wouldn't work in the UK where there is such a tiny market, for such niche medications...'he says.

'The model is low vol high unit price says Harrison .
'
And it needs to be a high unit price because that's how I can provide all the support services, like dieticians in a cost effective way and still make a margin.'


Now GDR is not charging high prices, though the NHS wanted to tweak them.
And strokes are sadly very common indeed.

As someone above said it needs to be either abroad where there is more of a tendency for genetic variant connection in strokes...though there is a certain proportion here naturally...or the US where this lifts us out of the difficulties of moving fast, it seems to me.
At least we are now looking at FDA approval.

What is most important, is keeping this company alive and kicking and refusing somebody else getting the benefit of these products, in my opinion, and in a cutting edge field!

IMO


Thanks to Hannah Prevett.

hazl
12/6/2025
13:55:16
Well he is useless as we know but obviously we can add disgusting to the list, with comments like that.

What a pity he is invested here.

hazl
12/6/2025
12:04:34
As we know, having a slick website is value accretive.

Idiot.

I take it hazl was badmouthing me. Sadly I can't see what she has to say, as I find the ramblings of an ex primary teacher in regards to stock market commentary about as useful as a nuns hymen.

premium beeksy
12/6/2025
11:01:13
Oh have they changed the website?
I thought it needed some tweaking.
I will have a look.

hazl
12/6/2025
10:56:46
....as does the chart....coiling up nicely. It will pop-soon.
socionomics
12/6/2025
10:56:12
Agreed, I think Beeks is pretty useless in every aspect of his life.

As an aside, it's looking really promising on the GDR front. The new device looks amazing :-) As does the website.

socionomics
12/6/2025
10:15:45
Some people get so jealous socio...take no notice...I don't.

Beeks tries hard but he's pretty useless.
The poster above seems to have appeared again as the other one seems to have disappeared.

What joy do they get out of life?

hazl
11/6/2025
19:44:53
When is next raise with the monthly cash burn so high?
indiangod
11/6/2025
15:11:45
I don't know about that Beeksy. Every aspect of GDR seems to be getting a little bit more slick (apart from sales). The devices, the website, the messaging. All on-point in my view.
socionomics
11/6/2025
14:44:16
The best kind of hazl moderation, imo.Still not a lot to get excited about here.
premium beeksy
11/6/2025
11:23:26
Time poor socio nomics.
hazl
11/6/2025
11:22:14
Self-moderating Hazl? :-)
socionomics
11/6/2025
11:17:12
And why not indeed.
hazl
11/6/2025
10:29:12
Here we go!
socionomics
11/6/2025
09:29:41
Some updates on NICE, FDA and UAE coming

May see a 3-5p move like last year

m_night10
09/6/2025
19:47:09
World population is increasing.

Nearly 58,000,000 births so far this year & counting:-

hxxps://www.worldometers.info/world-population/

marine boy
08/6/2025
08:38:28
I think the stroke test will make very much more impact because of the sheer numbers...especially in the East.
hazl
07/6/2025
21:08:26
Birth rate is on a massive decline across the globe.


The NHS won't place the baby hearing test kit as a priority in my opinion

indiangod
06/6/2025
11:28:19
I only follow the price action PB.
socionomics
06/6/2025
11:24:50
You aren't believing MKnight are you? Thick as mince that ramper, with probably a 2% success rate*

Makes Washing Machine look honest





*Margin of error +-2%

premium beeksy
06/6/2025
10:59:52
Very good posts this morning I must say!
Little fluff either, good and factual in the main.

That's whatwe need reminders of what is at stake.

And a dose of reality thrown in.

hazl
06/6/2025
10:56:55
First time in a while they've quoted for all of my GDR shares. (£37k).

Maybe something in the rumours. Doubt it, but you never know.

socionomics
Chat Pages: 1390  1389  1388  1387  1386  1385  1384  1383  1382  1381  1380  1379  Older

Top Brokers in the UK

Spread Bet
CFD
Forex
Share

Your Recent History

Delayed Upgrade Clock